Clinical Trial Update: Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing avatrombopag for adults with immune thrombocytopenia with autoantibodies, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Evans Syndrome
• Immune Thrombocytopenia

Drugs mentioned

• DOPTELET (avatrombopag)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Immune Thrombocytopenia, Autoantibodies | Phase 2 | Status: RECRUITING